Efficacy Testing Market by Type (Antimicrobial Efficacy Testing and Disinfectant Efficacy Testing), Product and Services (Consumables and Services), Application (Pharmaceutical Manufacturing, Cosmetic, and Personal Care Products): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026463 | Pages: 100 | Industry: Biotechnology | Date: Sep 2022 | Type: Global

The market crossed US$ 429.17 million mark in 2022 and is expected to hit US$ 844.77 million by 2030, recording a CAGR of 8.4% during the forecast period. 

Advantages of efficacy testing in different industries

The efficacy testing market has been significantly growing with the increasing adoption of R&D expenditure, the secure existence of major service providers, the support of government organizations, and the rising outsourcing of analytical testing (including efficacy testing) by pharmaceutical and cosmetic companies. Pharmaceutical and cosmetic products are addressing product safety, which also results in market growth. Due to bacterial pathogens and the overuse of antibiotics, the incidence of infection is increasing, leading to antibiotic resistance for fungal susceptibility in the bacterial organism. The factors supporting the antimicrobial efficacy testing market are the increasing use of rapid commercial antimicrobial susceptibility testing systems for fungal testing and the development of fungal susceptibility. An efficacy test is a laboratory test that determines a product's antimicrobial activity level and evaluates how well a product withstands microbial contamination during use. The testing provides two benefits to these industries; firstly, it considers the products to see what ultimate quantity of preservatives they should have. Secondly, it assesses the effects to see if they are preservative effectiveness testing.

Within the report, the market is segmented into type, product and services, application, and geography. By type, the market is further bifurcated into antimicrobial efficacy testing and disinfectant efficacy testing. Additionally, antimicrobial efficacy testing is sub-segmented into traditional test methods and rapid test methods. By disinfectant efficacy testing, the market is sub-segmented into surface test methods and suspension test methods. Based on application, the market is segmented into pharmaceutical manufacturing, cosmetic, and personal care products. Based on geography, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Increasing research and development outsourcing in the pharmaceutical sector fuels the market's growth

Pharmaceutical companies are outsourcing research and development activities to academic and private contract research organizations (CROs) at an increased level. It is used as a strategy to conduct primary research, such as safety and efficacy testing for product quality improvement and market products at lower costs, and overcome challenges associated with drug development. For instance, in February 2021, Eurofins Scientific, a global scientific leader in bioanalytical testing, announced the acquisition of Beacon Discovery, a notable drug discovery and contract research organization (CRO) focused on G-Protein Coupled Receptor (GPCR) research. 

Rising adoption in various industries is one of the major factors accelerating market growth.

The industries for the efficacy testing market are pharmaceutical manufacturers and cosmetic and personal care products. Within these industries, the pharmaceutical industry is one such sector wherein the use of efficacy testing is increasing for effective maintenance. For instance, the FDA's requirements for approval of new and generic drugs and biologics are among the world's highest standards. Before FDA approval, manufacturers prove that their products are high quality, safe, effective, and free of contamination and defects. In addition, manufacturers of non-application products, such as over-the-counter and homeopathic products, are responsible for adhering to quality standards. Cosmetic and personal care products are also encouraging the use of efficacy testing. Clinical testing of cosmetics and personal care products is crucial in substantiating the product claims for packaging and advertising while ensuring that the products are safe and effective for consumer use.

Recent strategic developments in the efficacy testing market

The efficacy testing market has undergone several significant developments, and a few of these have been mentioned below:

  • In August 2021, Eurofins announced the acquisition of bioskin GmbH full-service, dermatology-specific CRO specializing in drug trials, medical devices, food supplements, and advanced cosmetics. The aim is to diversify our clinical testing footprint in dermatology for medicinal products and medical devices

 

  • SGS launched a Biosafety Level-2 microbiology lab within their testing facility in Phoenix, Arizona. Comprising around 4,000 square feet, the lab will be concentrated on efficacy testing for hand sanitizers and antibacterial hand soaps

 

  • In Oct 2020, Eurofins introduced Europe’s first approved test technique for determining mask filtration capability for SARS-CoV-2

 

Several players drive the efficacy testing market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Charles River Laboratories, Becton Dickinson and Company, SGS SA, Eurofins Scientific, Merck KGaA, Biomérieux SA, Pacific BioLabs, Wuxi Apptec, North American Science Associates, and American Type Culture Collection are among the prominent players operating in the market.

The target audience for the report:

  • Raw material providers
  • Government bodies, such as regulating authorities and policymakers
  • Manufacturer
  • Venture capitalists, private equity firms, and start-up companies
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Product Type:
    • Antimicrobial Efficacy Testing
    • Disinfectant Efficacy Testing
  • Product and services:
    • Consumables
    • Services
  • Application:
  • Pharmaceutical Manufacturing
  • Cosmetic
  • Personal Care Products
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • South & Central America
    • Middle East & Africa
  • Companies profiled:
  • Merck KGaA
  • bioMérieux
  • Eurofins Discovery
  • Charles River Laboratories
  • Becton, Dickinson and Company
  • SGS SA
  • Pacific Biolabs Inc
  • WuXi AppTec
  • North American Science Associates, Inc.
  • American Type Culture Collection (ATCC)

Companies profiled:
- Merck KGaA
- bioM?rieux
- Eurofins Discovery
- Charles River Laboratories
- Becton, Dickinson and Company
- SGS SA
- Pacific Biolabs Inc
- WuXi AppTec
- North American Science Associates, Inc.
- American Type Culture Collection (ATCC)


Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000